Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency
Annals of Hematology · 2025
DOI: 10.1007/s00277-025-06205-4 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Hematology, 2025. Verfasst von Weiwei Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou TCM Hospital of Zhejiang Chinese Medical University Wenzhou, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Factor XII Deficiency, Factor XII. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou Science and Technology Bureau Project.
Abstract (Originalsprache)
Analyze the clinical phenotype and gene mutations of a family with hereditary FXII deficiency, and preliminarily explore its phenotypic manifestations. The routine coagulation indicators and related coagulation factors were measured.Thromboelastography and thrombin generation tests simulated coagulation and anticoagulation states in vitro and in vivo. PCR direct sequencing was utilized to analyze all exons and flanking sequences of the F12 gene in the proband, confirming suspected mutations through reverse sequencing, and identifying corresponding mutation sites in family members. Using ClustalX-2.1-win to analyze the conservation of the variant, and employing online software to predict the pathogenicity of mutations. The proband exhibited significantly prolonged APTT (169.1 s) and a pronounced decrease in FXII: C to 1.0%. Thromboelastography testing indicated a diminished function of the endogenous coagulation system, while thrombin generation testing revealed a normal ability for thrombin production in the proband. Gene sequencing revealed that the proband harbored a deletion mutation c.303_304delCA in exon 5 and a substitution mutation c.800 + 1G > A in intron 8. All three bioinformatics software indicated that the mutations were pathogenic and could lead to the production of a terminator, potentially altering the structure and function of the protein. The deletion mutation c.303_304delCA and substitution mutation c.800 + 1G > A are associated with a decreased in FXII levels in this family, with the c.800 + 1G > A mutation being the first reported mutation worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wenzhou TCM Hospital of Zhejiang Chinese Medical University Wenzhou, Wenzhou, Zhejiang, China.
- Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.…
Förderung
- Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province
- Wenzhou Science and Technology Bureau Project
Zitieren
APA
Fang, W., Chen, B., Zou, A., Xu, F., Qin, L., Yang, L., Wang, M., & Zhou, X. (2025). Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency. Annals of Hematology. https://doi.org/10.1007/s00277-025-06205-4
Vancouver
Fang W, Chen B, Zou A, Xu F, Qin L, Yang L, et al. Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency. Annals of Hematology. 2025. doi:10.1007/s00277-025-06205-4
BibTeX
@article{Fang2025,
author = {Fang, Weiwei and Chen, Bile and Zou, Anqing and Xu, Fei and Qin, Langyi and Yang, Lihong and Wang, Mingshan and Zhou, Xingxing},
title = {Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-025-06205-4}
}
EUVIMED